目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 23)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 27)
FIGURE 1 RESEARCH DESIGN
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Breakdown of primary interviews
2.1.2.2 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 4 BOTTOM-UP APPROACH: PROCEDURE-BASED ANALYSIS
2.2.1 GROWTH FORECAST
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 6 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS
2.5 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 37)
FIGURE 8 BONE CEMENT & GLUE MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 9 BONE CEMENT & GLUE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 10 BONE CEMENT & GLUE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 11 BONE CEMENT & GLUE MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 40)
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BONE CEMENT & GLUE MARKET
FIGURE 12 GROWING GERIATRIC POPULATION TO DRIVE MARKET
4.2 BONE CEMENT MARKET, BY TYPE
FIGURE 13 PMMA CEMENT TO REGISTER HIGHER GROWTH OVER FORECAST PERIOD
4.3 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY TYPE AND COUNTRY
FIGURE 14 US ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2022
4.4 BONE CEMENT & GLUE MARKET, BY COUNTRY
FIGURE 15 INDIA AND CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 44)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 BONE CEMENT & GLUE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing incidence of sports injuries
5.2.1.2 Rapid growth in geriatric population
TABLE 1 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050 (MILLION)
5.2.1.3 Developments in regenerative medicine
5.2.1.4 Growing number of road traffic accidents and other factors increasing surgery volumes
5.2.1.5 Technological advancements
5.2.2 RESTRAINTS
5.2.2.1 High costs and extensive clinical data requirements for launching new products
5.2.2.2 Alternatives to bone cement and glue
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging economies
5.2.3.2 Rising awareness and demand for minimally invasive procedures
5.2.4 CHALLENGES
5.2.4.1 Development of novel biomaterials with high mechanical properties and adhesion strength
5.2.4.2 Product-related complications
5.2.4.3 Unfavorable reimbursement scenario

6 BONE CEMENT & GLUE MARKET, BY TYPE (Page No. - 55)
6.1 INTRODUCTION
TABLE 2 BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
6.2 BONE CEMENT
TABLE 3 CONSTITUENTS OF BONE CEMENT
TABLE 4 BONE CEMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.1 BONE CEMENT MARKET, BY TYPE
TABLE 5 BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
6.2.1.1 PMMA cement
6.2.1.1.1 Wide usage and properties of PMMA to drive market
TABLE 6 PMMA CEMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.1.2 Calcium phosphate cement
6.2.1.2.1 High biocompatibility and radiopacity to drive adoption
TABLE 7 CPC MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.1.3 Glass polyalkenoate cement
6.2.1.3.1 Wide applications in dentistry to drive market
TABLE 8 GPC MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.2 BONE CEMENT MARKET, BY LOADING
TABLE 9 BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
6.2.2.1 Antibiotic-loaded bone cement
6.2.2.1.1 High risk of developing deep infections during surgeries to support adoption
TABLE 10 ANTIBIOTIC-LOADED BONE CEMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
6.2.2.2 Non-antibiotic-loaded bone cement
6.2.2.2.1 Low cost and less-stringent regulations to support usage
TABLE 11 NON-ANTIBIOTIC-LOADED BONE CEMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3 BONE GLUE
TABLE 12 BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 13 BONE GLUE MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3.1 NATURAL BONE GLUE
6.3.1.1 High biocompatibility to support greater adoption
TABLE 14 NATURAL BONE GLUE MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3.2 SYNTHETIC BONE GLUE
6.3.2.1 Emerging medical applications indicate high potential of synthetic glue
TABLE 15 SYNTHETIC BONE GLUE MARKET, BY REGION, 2021-2028 (USD MILLION)

7 BONE CEMENT & GLUE MARKET, BY APPLICATION (Page No. - 65)
7.1 INTRODUCTION
TABLE 16 BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
7.2 ARTHROPLASTY
TABLE 17 BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY REGION, 2021-2028 (USD MILLION)
TABLE 18 BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
7.2.1 TOTAL KNEE ARTHROPLASTY
7.2.1.1 TKA to hold largest arthroplasty market share
TABLE 19 BONE CEMENT & GLUE MARKET FOR TOTAL KNEE ARTHROPLASTY, BY REGION, 2021-2028 (USD MILLION)
7.2.2 TOTAL HIP ARTHROPLASTY
7.2.2.1 Growing geriatric population to boost procedural volumes
TABLE 20 BONE CEMENT & GLUE MARKET FOR TOTAL HIP ARTHROPLASTY, BY REGION, 2021-2028 (USD MILLION)
7.2.3 TOTAL SHOULDER ARTHROPLASTY
7.2.3.1 Rising sports injury incidence to drive market
TABLE 21 BONE CEMENT & GLUE MARKET FOR TOTAL SHOULDER ARTHROPLASTY, BY REGION, 2021-2028 (USD MILLION)
7.3 KYPHOPLASTY
7.3.1 INCREASING INCIDENCE OF OSTEOPOROSIS TO DRIVE MARKET
TABLE 22 TOP TEN COUNTRIES IN KYPHOPLASTY RESEARCH
TABLE 23 BONE CEMENT & GLUE MARKET FOR KYPHOPLASTY, BY REGION, 2021-2028 (USD MILLION)
7.4 VERTEBROPLASTY
7.4.1 RISING INCIDENCE OF VERTEBRAL COMPRESSION FRACTURES TO SUPPORT MARKET GROWTH
TABLE 24 BONE CEMENT & GLUE MARKET FOR VERTEBROPLASTY, BY REGION, 2021-2028 (USD MILLION)
7.5 OTHER APPLICATIONS
TABLE 25 BONE CEMENT & GLUE MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)

8 BONE CEMENT & GLUE MARKET, BY END USER (Page No. - 74)
8.1 INTRODUCTION
TABLE 26 BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
8.2 HOSPITALS & ASCS
8.2.1 HOSPITALS & ASCS TO DOMINATE END-USER MARKET
TABLE 27 BONE CEMENT & GLUE MARKET FOR HOSPITALS & ASCS, BY REGION, 2021-2028 (USD MILLION)
8.3 CLINICS & PHYSICIAN OFFICES
8.3.1 RISING PREFERENCE FOR CLINICS AND COST-SAVING POTENTIAL TO DRIVE MARKET
TABLE 28 BONE CEMENT & GLUE MARKET FOR CLINICS & PHYSICIAN OFFICES, BY REGION, 2021-2028 (USD MILLION)

9 BONE CEMENT & GLUE MARKET, BY REGION (Page No. - 78)
9.1 INTRODUCTION
TABLE 29 BONE CEMENT & GLUE MARKET, BY REGION, 2021-2028 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 17 NORTH AMERICA: BONE CEMENT & GLUE MARKET SNAPSHOT
TABLE 30 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 31 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 32 NORTH AMERICA: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 33 NORTH AMERICA: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 34 NORTH AMERICA: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 35 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 36 NORTH AMERICA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 37 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.2.2 US
9.2.2.1 Growing geriatric population and high prevalence of sports injuries to drive market
FIGURE 18 TOTAL ESTIMATED INJURIES BY SPORTS ACTIVITY IN 2021
TABLE 38 US: KEY MACROINDICATORS
TABLE 39 US: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 40 US: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 41 US: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 42 US: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 43 US: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 44 US: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 45 US: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Availability of government funding and growth in geriatric population to drive market
TABLE 46 FUNDS FOR SPORTS ORGANIZATIONS, 2021/2022 (USD THOUSAND)
TABLE 47 CANADA: KEY MACROINDICATORS
TABLE 48 CANADA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 49 CANADA: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 50 CANADA: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 51 CANADA: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 52 CANADA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 53 CANADA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 54 CANADA: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3 EUROPE
TABLE 55 EUROPE: BURDEN OF OSTEOPOROSIS (2021)
9.3.1 EUROPE: RECESSION IMPACT
TABLE 56 EUROPE: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 57 EUROPE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 58 EUROPE: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 59 EUROPE: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 60 EUROPE: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 61 EUROPE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 62 EUROPE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 63 EUROPE: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Rising government support to drive demand
TABLE 64 FRANCE: KEY MACROINDICATORS
TABLE 65 FRANCE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 66 FRANCE: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 67 FRANCE: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 68 FRANCE: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 69 FRANCE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 70 FRANCE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 71 FRANCE: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3.3 GERMANY
9.3.3.1 Robust healthcare spending and advanced healthcare system to favor market growth
TABLE 72 GERMANY: KEY MACROINDICATORS
TABLE 73 GERMANY: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 74 GERMANY: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 75 GERMANY: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 76 GERMANY: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 77 GERMANY: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 78 GERMANY: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 79 GERMANY: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3.4 UK
9.3.4.1 Presence of strong healthcare infrastructure and high burden of orthopedic cases
TABLE 80 UK: KEY MACROINDICATORS
TABLE 81 UK: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 82 UK: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 83 UK: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 84 UK: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 85 UK: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 86 UK: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 87 UK: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.3.5 REST OF EUROPE
TABLE 88 REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2021 (% OF GDP)
TABLE 89 REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 90 REST OF EUROPE: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 91 REST OF EUROPE: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 92 REST OF EUROPE: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 93 REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 94 REST OF EUROPE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 95 REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 19 ASIA PACIFIC: BONE CEMENT & GLUE MARKET SNAPSHOT
TABLE 96 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY COUNTRY/REGION, 2021-2028 (USD MILLION)
TABLE 97 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 98 ASIA PACIFIC: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 99 ASIA PACIFIC: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 100 ASIA PACIFIC: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 102 ASIA PACIFIC: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 103 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 China to hold largest market share in APAC
TABLE 104 CHINA: KEY MACROINDICATORS
TABLE 105 INCIDENCE OF OSTEOPOROTIC FRACTURES IN CHINA, 2015-2035
TABLE 106 CHINA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 107 CHINA: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 108 CHINA: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 109 CHINA: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 110 CHINA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 111 CHINA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 112 CHINA: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Rising medical tourism, improving healthcare infrastructure, and growing population to drive market
TABLE 113 INDIA: KEY MACROINDICATORS
TABLE 114 INDIA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 115 INDIA: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 116 INDIA: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 117 INDIA: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 118 INDIA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 119 INDIA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 120 INDIA: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4.4 JAPAN
9.4.4.1 Large aging population and favorable government initiatives to drive market
TABLE 121 JAPAN: KEY MACROINDICATORS
TABLE 122 JAPAN: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 123 JAPAN: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 124 JAPAN: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 125 JAPAN: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 126 JAPAN: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 127 JAPAN: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 128 JAPAN: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 129 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 130 REST OF ASIA PACIFIC: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 131 REST OF ASIA PACIFIC: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 132 REST OF ASIA PACIFIC: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 133 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 134 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 135 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 136 US VS. MEXICO: AVERAGE COST COMPARISON (USD)
9.5.1 ROW: RECESSION IMPACT
TABLE 137 REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 138 REST OF THE WORLD: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 139 REST OF THE WORLD: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
TABLE 140 REST OF THE WORLD: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 141 REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 142 REST OF THE WORLD: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 143 REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 131)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 144 OVERVIEW OF STRATEGIES ADOPTED BY KEY BONE CEMENT & GLUE MARKET PLAYERS
10.3 MARKET SHARE ANALYSIS, 2022
FIGURE 20 BONE CEMENT & GLUE MARKET SHARE ANALYSIS, 2022
TABLE 145 BONE CEMENT & GLUE MARKET: DEGREE OF COMPETITION (2022)
10.4 REVENUE SHARE ANALYSIS, 2022
FIGURE 21 REVENUE ANALYSIS OF TOP FOUR MARKET PLAYERS (USD MILLION)
10.5 COMPANY EVALUATION MATRIX, 2022
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 22 BONE CEMENT & GLUE MARKET: COMPANY EVALUATION MATRIX (2022)
10.6 COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 23 BONE CEMENT & GLUE MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
10.7 COMPETITIVE BENCHMARKING
TABLE 146 BONE CEMENT & GLUE MARKET: DETAILED LIST OF KEY SMES/STARTUPS
10.8 COMPANY FOOTPRINT ANALYSIS
TABLE 147 COMPANY FOOTPRINT ANALYSIS
TABLE 148 COMPANY PRODUCT FOOTPRINT
TABLE 149 COMPANY REGIONAL FOOTPRINT
10.9 COMPETITIVE SCENARIO
10.9.1 DEALS
TABLE 150 DEALS
10.9.2 OTHER DEVELOPMENTS
TABLE 151 OTHER DEVELOPMENTS

11 COMPANY PROFILES (Page No. - 142)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 STRYKER
TABLE 152 STRYKER: BUSINESS OVERVIEW
FIGURE 24 STRYKER: COMPANY SNAPSHOT (2022)
11.1.2 ZIMMER BIOMET
TABLE 153 ZIMMER BIOMET: BUSINESS OVERVIEW
FIGURE 25 ZIMMER BIOMET: COMPANY SNAPSHOT (2022)
11.1.3 HERAEUS HOLDING
TABLE 154 HERAEUS HOLDING: BUSINESS OVERVIEW
11.1.4 SMITH+NEPHEW
TABLE 155 SMITH+NEPHEW: BUSINESS OVERVIEW
FIGURE 26 SMITH & NEPHEW: COMPANY SNAPSHOT (2022)
11.1.5 DEPUY SYNTHES (JOHNSON & JOHNSON)
TABLE 156 JOHNSON & JOHNSON: BUSINESS OVERVIEW
FIGURE 27 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022)
11.1.6 ENOVIS
TABLE 157 ENOVIS: BUSINESS OVERVIEW
FIGURE 28 ENOVIS: COMPANY SNAPSHOT (2022)
11.1.7 ARTIVION, INC.
TABLE 158 ARTIVION, INC.: BUSINESS OVERVIEW
FIGURE 29 ARTIVION, INC.: COMPANY SNAPSHOT (2022)
11.1.8 CARDINAL HEALTH
TABLE 159 CARDINAL HEALTH: BUSINESS OVERVIEW
FIGURE 30 CARDINAL HEALTH.: COMPANY SNAPSHOT (2022)
11.1.9 MEDTRONIC
TABLE 160 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 31 MEDTRONIC: COMPANY SNAPSHOT (2022)
11.1.10 GLOBUS MEDICAL
TABLE 161 GLOBUS MEDICAL: BUSINESS OVERVIEW
FIGURE 32 GLOBUS MEDICAL: COMPANY SNAPSHOT (2022)
11.1.11 EXACTECH, INC.
TABLE 162 EXACTECH, INC.: BUSINESS OVERVIEW
11.1.12 ARTHREX, INC.
TABLE 163 ARTHREX, INC.: BUSINESS OVERVIEW
11.1.13 TEKNIMED
TABLE 164 TEKNIMED: BUSINESS OVERVIEW
11.1.14 TECRES S.P.A.
TABLE 165 TECRES S.P.A.: BUSINESS OVERVIEW
11.1.15 BIOCERAMED S.A.
TABLE 166 BIOCERAMED, S.A.: BUSINESS OVERVIEW
11.1.16 EVOLUTIS
TABLE 167 EVOLUTIS: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 NORMMED MEDICAL
11.2.2 LINACOL MEDICAL INC.
11.2.3 BPB MEDICA
11.2.4 IZI MEDICAL
11.2.5 ADITUS MEDICAL
11.2.6 OSARTIS GMBH
11.2.7 LD DAVIS
11.2.8 MILLIGAN & HIGGINS
11.2.9 VHERN S.R.L.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 179)
12.1 INDUSTRY INSIGHTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 CUSTOMIZATION OPTIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS